HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rafal Suwinski Selected Research

Neoplasms (Cancer)

5/2023Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer.
9/2022International consensus on radiotherapy in metastatic non-small cell lung cancer.
5/2021Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer.
12/2020Randomised clinical trial on 7-days-a-week postoperative radiotherapy vs. concurrent postoperative radio-chemotherapy in locally advanced cancer of the oral cavity/oropharynx.
1/2016Randomized clinical trial on 7-days-a-week post-operative radiotherapy vs concurrent post-operative radiochemotherapy in locally advanced cancer of the oral cavity/oropharynx: a report on acute normal tissue reactions.
1/2012Gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancer.
1/2012PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.
6/2010Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial.
11/2006Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: long-term results of phase III clinical trial.
11/2004The erythropoietin-receptor pathway modulates survival of cancer cells.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rafal Suwinski Research Topics

Disease

11Neoplasms (Cancer)
05/2023 - 06/2003
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2023 - 05/2021
5Head and Neck Neoplasms (Head and Neck Cancer)
05/2011 - 06/2003
3Neoplasm Metastasis (Metastasis)
09/2022 - 06/2003
3Brain Neoplasms (Brain Tumor)
12/2021 - 04/2021
3Mucositis
03/2013 - 10/2005
3Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2012 - 06/2010
2Lung Neoplasms (Lung Cancer)
05/2023 - 01/2012
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2021 - 04/2007
2Squamous Cell Carcinoma of Head and Neck
03/2013 - 11/2006
1Lewis Lung Carcinoma
05/2023
1Oropharyngeal Neoplasms
12/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2016
1Papillomavirus Infections
05/2011
1Laryngeal Neoplasms (Laryngeal Cancer)
11/2007
1Rectal Neoplasms (Rectal Cancer)
11/2007
1Stomach Neoplasms (Stomach Cancer)
02/2007
1Necrosis
11/2006
1Erythema
10/2005
1Body Weight (Weight, Body)
10/2005
1Anemia
11/2004
1Urinary Bladder Neoplasms (Bladder Cancer)
09/2004
1Margins of Excision
06/2003

Drug/Important Bio-Agent (IBA)

7carboxyaminoimidazole ribotide (CAIR)IBA
01/2016 - 10/2005
2RNA (Ribonucleic Acid)IBA
05/2023 - 01/2012
2Hemoglobins (Hemoglobin)IBA
11/2007 - 09/2004
1Complement C5a (Complement 5a)IBA
05/2023
1Therapeutic UsesIBA
05/2023
1ErbB Receptors (EGF Receptor)IBA
12/2021
1Immune Checkpoint InhibitorsIBA
12/2021
1Cyclin D1IBA
01/2012
1Messenger RNA (mRNA)IBA
01/2012
1Cyclin DIBA
05/2011
1Erythropoietin Receptors (Erythropoietin Receptor)IBA
11/2004
1ErythropoietinFDA Link
11/2004

Therapy/Procedure

21Radiotherapy
05/2023 - 06/2003
4Therapeutics
05/2021 - 06/2010
4Drug Therapy (Chemotherapy)
04/2021 - 04/2007
2Immunotherapy
12/2022 - 05/2021
2Chemoradiotherapy
01/2016 - 02/2007
1Cranial Irradiation
04/2021
1Brachytherapy
01/2016
1Gastrectomy
02/2007
1Duration of Therapy
06/2003